ATE229277T1 - Proteinmaterial mit verlangsamtem verdaungsablauf und deren verwendung - Google Patents

Proteinmaterial mit verlangsamtem verdaungsablauf und deren verwendung

Info

Publication number
ATE229277T1
ATE229277T1 AT99952602T AT99952602T ATE229277T1 AT E229277 T1 ATE229277 T1 AT E229277T1 AT 99952602 T AT99952602 T AT 99952602T AT 99952602 T AT99952602 T AT 99952602T AT E229277 T1 ATE229277 T1 AT E229277T1
Authority
AT
Austria
Prior art keywords
protein material
digesting
proteins
slow
digestion process
Prior art date
Application number
AT99952602T
Other languages
English (en)
Inventor
Olivier Ballevre
Clara L Garcia-Rodenas
Kristel Reiffers-Magnani
Bernard Beaufrere
Martial Dangin
Francois Couzy
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE229277T1 publication Critical patent/ATE229277T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Treatment Of Sludge (AREA)
AT99952602T 1998-10-16 1999-10-14 Proteinmaterial mit verlangsamtem verdaungsablauf und deren verwendung ATE229277T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203452 1998-10-16
PCT/EP1999/007909 WO2000022937A1 (fr) 1998-10-16 1999-10-14 Matiere proteique a digestion ralentie et son utilisation

Publications (1)

Publication Number Publication Date
ATE229277T1 true ATE229277T1 (de) 2002-12-15

Family

ID=8234217

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99952602T ATE229277T1 (de) 1998-10-16 1999-10-14 Proteinmaterial mit verlangsamtem verdaungsablauf und deren verwendung

Country Status (14)

Country Link
US (1) US6355612B1 (de)
EP (1) EP1148791B1 (de)
JP (1) JP2002527457A (de)
CN (1) CN1273030C (de)
AT (1) ATE229277T1 (de)
AU (1) AU6473999A (de)
BR (1) BR9914594A (de)
CA (1) CA2347172A1 (de)
DE (1) DE69904511T2 (de)
DK (1) DK1148791T3 (de)
ES (1) ES2188259T3 (de)
HK (1) HK1041790B (de)
PT (1) PT1148791E (de)
WO (1) WO2000022937A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6838431B2 (en) * 1999-07-27 2005-01-04 Pacific Health Laboratories, Inc. Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety
US6207638B1 (en) 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
DE10056345A1 (de) * 2000-11-14 2002-05-29 Rettenmaier & Soehne Gmbh & Co Futtermittel
AU2002232575A1 (en) 2000-12-15 2002-06-24 Pacifichealth Laboratories, Inc. Nutritional composition for improving the efficacy of a lipase inhibitor
US6429190B1 (en) 2000-12-15 2002-08-06 Pacifichealth Laboratories, Inc. Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK)
NL1019931C2 (nl) * 2002-02-08 2003-08-11 Tno Verzadiging opwekkend voedingsmiddel.
US20030194423A1 (en) * 2002-04-15 2003-10-16 Mars, Inc. Composition for enhancing nutritional content of food
EP1578209A1 (de) * 2002-12-20 2005-09-28 Mars Uk Limited Futterprofil für katzen
EP1811865B1 (de) * 2004-11-26 2008-07-16 N.V. Nutricia Kleinkindernahrung mit proteasehemmer
BRPI0519642A8 (pt) 2004-12-29 2017-10-03 Hill´S Pet Nutrition Inc Método para inibir um declínio em aprendizagem e/ou memória, kit apropriado para administrar um ou mais antioxidantes a um animal, meio para transmitir informação, e, uso de uma composição
BRPI0613000A2 (pt) 2005-07-14 2012-12-04 Hills Pet Nutrition Inc método para aumentar a longevidade de um animal, artigo de fabricação, kit, e, meio de comunicação de informação acerca de ou instruções para a administração a um animal velho de uma composição
EP2074891A1 (de) * 2007-12-21 2009-07-01 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Neue hungerunterdrückende Nahrungsmittelzusammensetzungen
RU2525577C2 (ru) * 2009-03-11 2014-08-20 Нестек С.А. Пищевые композиции кусочков в подливе
EP2453759B1 (de) * 2009-07-14 2015-10-21 Hill's Pet Nutrition, Inc. Haustierfuttermittel enthaltend einer verzögerten freisetzung form von liponsäure, deren verwendung und herstellungsverfahren
EP2583563A1 (de) 2011-10-21 2013-04-24 Nestec S.A. Molkeproteinmizellen gegen Muskelatrophie und Sarkopenie
WO2013087419A1 (en) 2011-12-14 2013-06-20 Nestec S.A. Emulsified food product containing dairy protein
FR3002831B1 (fr) * 2013-03-11 2015-07-17 Lactalis Nutrition Sante Produit alimentaire pret a consommer pour patients atteints d'une maladie du metabolisme d'un ou de plusieurs acides amines
EP2968430A1 (de) 2013-03-15 2016-01-20 The Iams Company Zusammensetzung und verfahren zur verhinderung, reduzierung, linderung oder behandlung von idiopathischem erbrechen
AU2014228552A1 (en) 2013-03-15 2015-10-08 Mars, Incorporated Composition and method for preventing, reducing, alleviating, or treating idiopathic vomiting
CN104082739B (zh) * 2014-06-24 2016-06-15 广州纽健生物科技有限公司 一种全营养半消化特殊医学用途配方食品及其制备方法
EP3200609B1 (de) 2014-09-30 2019-05-08 Mars, Incorporated Auf ablehnung basierendes verfahren zur feststellung der nahrungspräferenz von katzen oder hunden
US10251913B2 (en) 2014-11-19 2019-04-09 Nestec S.A. Use of whey protein micelles and polysaccharides for improving insulin profile
TR201908045T4 (tr) * 2014-11-19 2019-06-21 Nestec Sa Peynir Altı Suyu Protein Miselleri Ve Pektin Karışımının Vücut Ağırlığını Kontrol Amaçlı Kullanımı.
WO2016078956A1 (en) * 2014-11-19 2016-05-26 Nestec S.A. Complexes of whey protein micelles and pectin and body muscle protein synthesis
CN120436205A (zh) 2015-02-13 2025-08-08 马斯公司 包装宠物食物产品
GB201522304D0 (en) 2015-12-17 2016-02-03 Mars Inc Food product for reducing muscle breakdown
IT201800006268A1 (it) * 2018-06-13 2019-12-13 Formulazione nutrizionale per la gestione della dieta per la fenilchetonuria e metodo di realizzazione
JP7432741B2 (ja) * 2020-02-10 2024-02-16 マース インコーポレーテッド カロリー制限および飽食効果のための膨張乾燥製品、その使用およびその製造方法
CN111317124A (zh) * 2020-04-22 2020-06-23 苏州罗得威尔生物科技有限公司 一种食品胶体与淀粉复配并结合物理处理制备缓慢消化淀粉的方法
CN114304369A (zh) * 2020-09-29 2022-04-12 内蒙古伊利实业集团股份有限公司 一种乳清蛋白组合物及其制备方法和应用
CN114027390A (zh) * 2021-11-26 2022-02-11 安琪纽特股份有限公司 一种酵母蛋白、其组合物及其制备方法和应用
AU2024365830A1 (en) 2023-10-27 2026-04-09 Société des Produits Nestlé S.A. Paediatric formulations for phenylketonuria and tyrosinaemia and specific free amino acid mixture
CN117837768B (zh) * 2024-01-09 2025-11-18 南京财经大学 杏鲍菇蛋白-燕麦β-葡聚糖复合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053497T3 (es) * 1986-10-27 1994-08-01 Abbott Lab Formulas nutritivas liquidas para la intolerancia a la glucosa.
DK0799577T3 (da) 1994-10-14 2001-06-18 Morinaga Milk Industry Co Ltd Peptidblanding og produkter deraf
AU5701996A (en) * 1995-05-17 1996-11-29 Yamanouchi Pharmaceutical Co., Ltd. Water-soluble extract originating in feather cockscomb
EP0749697A1 (de) * 1995-06-22 1996-12-27 Hercules Incorporated Beschichtetes Nahrungsmittel
CA2228954A1 (en) 1995-08-08 1997-02-20 Milupa Gmbh & Co. Kg Protein composition
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate

Also Published As

Publication number Publication date
AU6473999A (en) 2000-05-08
ES2188259T3 (es) 2003-06-16
EP1148791B1 (de) 2002-12-11
US6355612B1 (en) 2002-03-12
PT1148791E (pt) 2003-04-30
WO2000022937A1 (fr) 2000-04-27
CN1273030C (zh) 2006-09-06
BR9914594A (pt) 2001-06-26
CN1323165A (zh) 2001-11-21
DE69904511T2 (de) 2003-05-28
CA2347172A1 (en) 2000-04-27
HK1041790B (zh) 2007-04-13
HK1041790A1 (zh) 2002-07-26
DE69904511D1 (de) 2003-01-23
JP2002527457A (ja) 2002-08-27
DK1148791T3 (da) 2003-03-24
EP1148791A1 (de) 2001-10-31

Similar Documents

Publication Publication Date Title
DE69904511D1 (de) Proteinmaterial mit verlangsamtem verdaungsablauf und deren verwendung
AR001731A1 (es) Nueva celulasa método para producirla composición que la contiene vector que comprende al adn que lacodifica celula huesped método de aplicación
Woychik et al. Reduction and starch-gel electrophoresis of wheat gliadin and glutenin
MX2024010472A (es) Polipeptidos que enlazan adamts5, mmp13 y agrecano.
DE69826465D1 (de) Verfahren zur in vitro evolution von proteinfunktionen
EA200000652A1 (ru) Кристаллы глюкагоноподобного пептида 1
DE69634912D1 (de) Intrazellulare domäne des her-2/neu proteins, für die prevention oder behandlung von bösartigen tumoren
DE69934967D1 (de) Verfahren zur verminderung der immunogenität von proteinen
DE3469534D1 (en) Modified proteinase inhibitors, process for their preparation and pharmaceutical compositions containing them
EA200200105A1 (ru) СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ PPARγ;
ATE267255T1 (de) Ob proteinderivate mit verlängerter halbwertzeit
CY1105772T1 (el) Συνθεσεις και μεθοδοι για βελτιωμενη κυτταρικη καλλιεργεια
MXPA04000428A (es) Alimento que contiene proteina que comprende una enzima de entrelazamiento y un hidrocoloide.
EP0578738A4 (de) Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen.
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
GB0010314D0 (en) Anti-freeze proteins their production and use
AR001732A1 (es) Celulasa alcalina novedosa y método para producirla
IE820637L (en) Dipeptides
IL187595A0 (en) Antitumor antibodies, proteins, and uses thereof
BR9712575A (pt) Processo para restaurar em células que apresentam uma proteìna p53 que sofreu mutação , uma atividade de transactivação p53-dependente, utilizações de um anticorpo de cadeia simples capaz de ligar especificamente uma proteìna p53 que sofreu mutação, e de um ácido nucleico codificante, molécula 11d3 ou uma variante, ácido nucleico e composição
MXPA02010643A (es) Un metodo de tratamiento de proteinas de soya y un producto de proteina de soya producido mediante este metodo.
Fujii et al. Aldehyde content and cross-linking of type III collagen
DE60036555D1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
JPS5718995A (en) Production of low-molecular-weight peptide composition
Xu et al. Purification and identification of angiotensin I‐converting enzyme‐inhibitory peptides from apalbumin 2 during simulated gastrointestinal digestion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1148791

Country of ref document: EP

REN Ceased due to non-payment of the annual fee